Bulk Manufacturer of Controlled Substances Application: Invizyne Technologies, Inc., 7173-7174 [2025-01347]
Download as PDF
7173
Federal Register / Vol. 90, No. 12 / Tuesday, January 21, 2025 / Notices
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DEPARTMENT OF JUSTICE
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before March 24, 2025. Such
persons may also file a written request
for a hearing on the application on or
before March 24, 2025.
[Docket No. DEA–1477]
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 27, 2024,
Groff Health Inc., 2218 South Queen
Street, York, Pennsylvania 17402–4631
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Psilocybin .......................
Psilocyn ..........................
I
Drug
code
Schedule
7437
7438
I
I
I
The company plans to bulk
manufacture the listed controlled
substances for internal use or for sale to
its customers. No other activities for
these drug codes are authorized for this
registration.
ddrumheller on DSK120RN23PROD with NOTICES1
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–01349 Filed 1–17–25; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
19:56 Jan 18, 2025
Jkt 265001
Drug
code
Schedule
9050
9143
9150
9193
9250
9254
9300
9330
9333
9630
9652
9780
II
II
II
II
II
II
II
II
II
II
II
II
Drug Enforcement Administration
DATES:
Controlled substance
Controlled substance
Bulk Manufacturer of Controlled
Substances Application: Siegfried
USA, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Siegfried USA, LLC has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before March 24, 2025. Such
persons may also file a written request
for a hearing on the application on or
before March 24, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on November 20, 2024,
Siegfried USA, LLC, 33 Industrial Park
Road, Pennsville, New Jersey 08070–
3244 applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUMMARY:
Controlled substance
Gamma Hydroxybutyric
Acid.
Dihydromorphine ............
Hydromorphinol ..............
Amphetamine .................
Lisdexamfetamine ..........
Methylphenidate .............
Amobarbital ....................
Pentobarbital ..................
Secobarbital ....................
PO 00000
Frm 00103
Fmt 4703
Drug
code
Schedule
2010
I
9145
9301
1100
1205
1724
2125
2270
2315
I
I
II
II
II
II
II
II
Sfmt 4703
Codeine ..........................
Oxycodone .....................
Hydromorphone ..............
Hydrocodone ..................
Methadone ......................
Methadone intermediate
Morphine .........................
Oripavine ........................
Thebaine .........................
Opium tincture ................
Oxymorphone .................
Tapentadol ......................
The company plans to bulk
manufacture the listed controlled
substances in bulk for sale to its
customers. No other activities for these
drug codes are authorized for this
registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–01350 Filed 1–17–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1474]
Bulk Manufacturer of Controlled
Substances Application: Invizyne
Technologies, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Invizyne Technologies, Inc.
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before March 24, 2025. Such
persons may also file a written request
for a hearing on the application on or
before March 24, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
SUMMARY:
E:\FR\FM\21JAN1.SGM
21JAN1
7174
Federal Register / Vol. 90, No. 12 / Tuesday, January 21, 2025 / Notices
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on November 14, 2024,
Invizyne Technologies, Inc., 750 Royal
Oaks Drive, Suite 106, Monrovia,
California 91016–6357 applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Drug
code
Schedule
7370
I
Tetrahydrocannabinols ...
The company plans to bulk
manufacture the listed controlled
substance for the internal use
intermediates or for sale to its
customers. In reference to drug code
7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture this
drug as synthetic. No other activity for
this drug code is authorized for this
registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–01347 Filed 1–17–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
National Institute of Justice
[OJP (NIJ) Docket No. 1833]
Body Armor Manufacturer Workshop
National Institute of Justice,
Office of Justice Programs, U.S.
Department of Justice.
ACTION: Notice.
AGENCY:
The National Institute of
Justice (NIJ) will hold an online
workshop for body armor manufacturers
to provide updates on its standards and
conformity assessment activities related
to ballistic-resistant body armor.
DATES: The workshop will be held
online Wednesday, March 19, 2025,
from 1 p.m. to 3 p.m. eastern time.
FOR FURTHER INFORMATION CONTACT:
Jared Gardner, Technology and
Standards Advisor, Office of
Technology and Standards, National
Institute of Justice, 999 North Capitol
Street NE, Washington, DC 20531, by
telephone at (202) 702–2917 [Note: this
is not a toll-free telephone number], or
by email at jared.gardner@usdoj.gov.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
19:56 Jan 18, 2025
Jkt 265001
The
National Institute of Justice (NIJ) will
hold an online workshop for body armor
manufacturers to provide updates on its
standards and conformity assessment
activities related to ballistic-resistant
body armor. NIJ will discuss recent
addenda to NIJ Standard 0101.07,
‘‘Ballistic Resistance of Body Armor’’,
and NIJ Standard 0123.00,
‘‘Specification for NIJ Ballistic
Protection Levels and Associated Test
Threats’’. The NIJ Compliance Testing
Program (CTP) will update program
participants on the initial
implementation of testing body armor to
NIJ Standard 0101.07 (‘‘07’’) and the
anticipated timeline for publication of
the NIJ Compliant Products List (CPL)
for those ‘‘07’’ armor models. The NIJ
CTP will also discuss ongoing
administration of the NIJ CPL for armor
compliant with NIJ Standard 0101.06
(‘‘06’’) and continued Follow-up
Inspection and Testing (FIT) for those
‘‘06’’ armor models. Potential revisions
to NIJ CTP program requirements will
also be discussed, including FIT testing
procedures for ‘‘07’’ armor models listed
on the NIJ CPL, disclosure of
information about ballistic materials
used to manufacture body armor
submitted to the NIJ CTP for
certification, and labeling requirements,
among others. NIJ will also discuss
potential changes to how information is
displayed on the NIJ Compliant
Products List and how it anticipates
future updates to NIJ standards and NIJ
CTP program requirements will be
communicated.
The workshop will be presented as an
online webinar with opportunities for
attendees to ask questions. To register
for the workshop, please send an email
to askctp@nijctp.org by 5 p.m. eastern
time on Friday, March 14, 2025, and
provide the name of your company and
the names of the representatives who
will attend. Please put ‘‘Body Armor
Manufacturer Workshop’’ in the subject
line of the email. A preliminary agenda
will be sent to registered attendees
approximately 48 hours prior to the
workshop.
For more information on NIJ’s
standards and conformity assessment
activities, please visit https://
nij.ojp.gov/topics/equipment-andtechnology/standards-and-conformityassessment. For more information on
body armor, please visit https://
nij.ojp.gov/topics/equipment-andtechnology/body-armor. More
information on the NIJ CTP can be
found here: https://cjttec.org/
compliance-testing-program/.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
NIJ publishes this notice pursuant to
its authority at 34 U.S.C. 10122(c) and
6 U.S.C. 161–165.
Nancy La Vigne,
Director, National Institute of Justice.
[FR Doc. 2025–01247 Filed 1–17–25; 8:45 am]
BILLING CODE 4410–18–P
DEPARTMENT OF LABOR
Employee Benefits Security
Administration
[Exemption Application No. D–12101]
Proposed Exemption From Certain
Prohibited Transaction Restrictions
Involving Northern Trust Corporation
(Together With its Current and Future
Affiliates, Northern or the Applicant)
Located in Chicago, IL
Employee Benefits Security
Administration, Labor.
ACTION: Notice of proposed exemption.
AGENCY:
This document provides
notice of the pendency before the
Department of Labor (the Department) of
a proposed individual exemption from
certain prohibited transaction
restrictions of the Employee Retirement
Income Security Act of 1974 (ERISA)
and the Internal Revenue Code of 1986
(the Code). The proposed exemption
would allow certain entities with
specified relationships to Northern
Trust Fiduciary Services (Guernsey)
Limited (NTFS) (hereinafter, the
Northern QPAMs, as further defined in
section I(e) of the operative language) to
rely on the exemptive relief provided by
Prohibited Transaction Class Exemption
84–14 (PTE 84–14 or the QPAM
Exemption), notwithstanding the
judgment of conviction (the Conviction)
against NTFS for aiding and abetting tax
fraud entered in France in the Paris
Court of Appeal, French Special
Prosecutor No. 1120392066, French
Investigative Judge No. JIRSIF/11/12.
DATES:
Exemption date: This proposed
exemption would be in effect for a
period of five years beginning on March
5, 2025, and ending on March 4, 2030
(the Exemption Period).
Comments due: Written comments
and requests for a public hearing on the
proposed exemption should be
submitted to the Department by March
7, 2025.
ADDRESSES: All written comments and
requests for a hearing should be
submitted to the Employee Benefits
Security Administration (EBSA), Office
of Exemption Determinations,
Attention: Application No. D–12101 via
SUMMARY:
E:\FR\FM\21JAN1.SGM
21JAN1
Agencies
[Federal Register Volume 90, Number 12 (Tuesday, January 21, 2025)]
[Notices]
[Pages 7173-7174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-01347]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1474]
Bulk Manufacturer of Controlled Substances Application: Invizyne
Technologies, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Invizyne Technologies, Inc. has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
March 24, 2025. Such persons may also file a written request for a
hearing on the application on or before March 24, 2025.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be
[[Page 7174]]
aware that submitted comments are not instantaneously available for
public view on https://www.regulations.gov. If you have received a
Comment Tracking Number, your comment has been successfully submitted
and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on November 14, 2024, Invizyne Technologies, Inc., 750
Royal Oaks Drive, Suite 106, Monrovia, California 91016-6357 applied to
be registered as a bulk manufacturer of the following basic class(es)
of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substance for the internal use intermediates or for sale to its
customers. In reference to drug code 7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture this drug as synthetic. No other
activity for this drug code is authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-01347 Filed 1-17-25; 8:45 am]
BILLING CODE P